Anxiety and addiction almost always arrive together at Jintara.

Anxiety disorder and addiction are co-occurring conditions where each one continuously intensifies the other. A person experiencing generalised anxiety disorder, social anxiety, or panic disorder often reaches for alcohol, benzodiazepines, or cannabis because these substances produce fast, reliable relief (NIMH on anxiety disorders) that therapy and lifestyle change cannot deliver in the same timeframe. The substance works. That is the problem.

Over time, the brain adjusts. The same dose that quieted anxiety three months ago now barely touches it. The person increases use to maintain the effect. When they stop, anxiety surges back, often far worse than it was before they started using. By the time someone calls Jintara, many are not just anxious: they are terrified of what will happen to their mental state if they stop.

This is why treating anxiety and addiction separately rarely produces lasting results. Our dual diagnosis program is built around the clinical reality that the two conditions share the same neurobiological roots and need to be addressed in parallel.

Alcohol suppresses the central nervous system rapidly, which is why it feels effective for anxiety. The problem is that the suppression is temporary and the rebound is real. As alcohol clears the bloodstream, the nervous system overshoots its resting state, producing rebound anxiety: a period of heightened arousal, irritability, and dread that arrives several hours after the last drink. People in this state often drink again to stop it. The pattern becomes self-sustaining.

Benzodiazepines follow the same pharmacological logic at a more pronounced scale. They bind to the same receptors that alcohol affects, but with greater potency and a longer rebound period. Clients who have been using benzodiazepines daily for months or years often experience severe anxiety as a withdrawal symptom, sometimes indistinguishable from panic disorder. Separating the withdrawal from the underlying condition takes several weeks of careful observation.

Both alcohol and benzodiazepine withdrawal require medical supervision. Benzodiazepine withdrawal in particular carries risks that make unsupervised cessation dangerous. At Jintara, the nursing team monitors clients around the clock through the acute withdrawal phase, adjusting medication to prevent the anxiety spiral that most commonly drives early departure from treatment.

Cannabis is the most commonly self-reported substance for anxiety management, yet it is also a well-established driver of anxiety escalation with regular use. Low doses of cannabis may reduce acute anxiety for some people; higher doses and long-term use are associated with increased anxiety, paranoia, and in some cases substance-induced psychosis. Clients who arrive at Jintara using cannabis for anxiety often find that their baseline anxiety decreases significantly once cannabis use stops, usually within the first two weeks.

Stimulants, including methamphetamine and cocaine, produce a different presentation. Both substances directly activate the fight-or-flight system, meaning that anxiety during active stimulant use is often acute and intense. In early recovery, people recovering from stimulant use frequently experience a crash phase characterised by fatigue, low mood, and flat affect rather than anxiety. As the brain restores its natural dopamine balance over subsequent weeks, anxiety symptoms may re-emerge as an underlying condition that was previously masked.

Jintara's clinical team assesses each substance's contribution to a client's anxiety separately. What looks like a single anxiety disorder on admission often turns out to be a combination of substance-induced symptoms and a pre-existing vulnerability, which is why the first step in treatment is reaching clarity of mind. For clients whose primary substance is alcohol, the alcohol addiction program provides more detail on what the withdrawal and recovery pathway looks like.

Clinical assessment for co-occurring anxiety begins on the first day of admission. The team uses two validated clinical screening tools: the Patient Health Questionnaire (PHQ-9) for depression and the Generalized Anxiety Disorder scale (GAD-7) for anxiety. These provide a baseline score before any therapeutic work begins. A high GAD-7 on admission does not automatically indicate a clinical anxiety disorder: it may reflect acute withdrawal, fear about entering treatment, or the disorientation of being in a new environment.

The diagnostic picture becomes clearer after two weeks. If a client's GAD-7 score drops significantly and they report feeling calmer, the clinical team can say with reasonable confidence that the anxiety was largely substance-induced. If scores remain high or worsen despite stabilization, the team treats it as an underlying condition that needs its own therapeutic track.

Lertkhwan Sukpia, Jintara's Head Nurse, leads the nursing observation that runs alongside formal screening. Khun Khwan's team tracks sleep quality, appetite, group attendance, and behavioral signs of anxiety throughout each day. Their notes feed directly into Denise's therapy planning. No single tool makes the diagnosis: it is the accumulation of observation over time.

During the first two weeks of a 30-day program, the clinical priority for clients with anxiety is stabilization, not resolution. Denise does not conduct deep trauma processing or intensive cognitive restructuring during this phase. The reasoning is clear: a client whose nervous system is still recalibrating from withdrawal cannot engage with deeper therapeutic work safely. Opening significant psychological material during this window risks creating distress the client does not yet have the tools to manage.

What stabilization looks like in practice involves grounding techniques to bring the nervous system down from activation, sleep hygiene work to restore rest patterns, and individual sessions focused on the immediate emotional experience rather than its roots. The structured daily schedule functions as treatment in itself: meals at fixed times, groups morning and afternoon, exercise, and a 10 PM curfew that signals the body to rest.

For clients with anxiety, following a schedule removes the most common anxiety driver: open-ended uncertainty. When every hour of the day has a clear next step, the mind has fewer gaps to fill with worst-case thinking. By day 14, many clients describe feeling calmer than they have in months. Our program overview explains the full structure of what a typical week looks like across the 30 days.

Cognitive Behavioral Therapy is the primary psychotherapy approach for anxiety at Jintara. In the group setting, Denise uses the ABC model: identifying the Activating event, the Beliefs formed about it, and the Consequences in emotion and behavior. For people with anxiety and addiction, automatic negative thoughts tend to be fast, habitual, and highly plausible-feeling. The goal of CBT is not to argue against these thoughts but to slow them down, examine whether they are accurate, and practice generating more balanced interpretations.

Groups are not separated by diagnosis. A client with anxiety attends the same groups as other clients, because the skills taught, including thought spotting, behavioral activation, and nervous system regulation, are relevant across presentations. The group also provides a social mirror: for someone whose anxiety has led to increasing isolation, attending and surviving a group of up to ten peers is itself a therapeutic act.

Individual sessions address what group therapy cannot reach: the specific fears, the particular thought loops, the relationship patterns that keep anxiety alive. Denise tailors each session to where the client is that day. Anyone considering treatment for co-occurring anxiety is welcome to speak with our admissions team before committing.

Not all anxiety is the same. For some clients, anxiety is a learned pattern of fearful thinking that responds well to CBT. For others, it is rooted in specific unprocessed memories: a traumatic event, sustained childhood stress, or repeated experiences of threat that the nervous system has never fully processed. For this second group, CBT alone may reduce symptoms without addressing their origin. EMDR therapy, Eye Movement Desensitization and Reprocessing, is designed for this presentation.

At Jintara, EMDR is not automatically assigned to every client. It requires clinical assessment of readiness, a history of trauma that has been identified and discussed with the therapist, and a minimum commitment to an extended stay. Denise does not begin EMDR processing during a 30-day program. The first month is dedicated to stabilization and addiction work. Deep trauma processing begins in the second month for clients who commit to 60 days.

For clients on a 30-day program who have anxiety rooted in trauma, the focus is preparation: identifying the specific memories relevant to processing, building the grounding tools that make processing safe, and establishing the therapeutic relationship required for this work. Clients leave with a clear discharge summary so that an EMDR therapist at home can continue exactly where Jintara left off.